P
PepLab Solutions
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X | 1 | 7.6 | 7.6 | 7.6 | 25 May 2026 |
| 4-Anilinopiperidine CAS 99918-43-1 | X | 1 | 4.0 | 0.0 | 0.0 | 6 May 2025 |
| 5-amino-1MQ | X | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| AICAR Oral | X | 1 | 4.0 | 0.4 | 0.4 | 27 Feb 2025 |
| Andarine S4 | X | 1 | 4.0 | 2.2 | 2.2 | 2 Apr 2025 |
| BPC157 5mg + TB500 5mg Blend | X | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| Cabergoline | X | 1 | 4.0 | 2.5 | 2.5 | 13 Jun 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X | 1 | 4.0 | 0.7 | 0.7 | 13 Feb 2025 |
| DHB (1-Test Cyp) | X | 1 | 4.0 | 2.3 | 2.3 | 2 Apr 2025 |
| GHRP-6 Acetate | X | 1 | 4.0 | 0.8 | 0.8 | 16 Mar 2025 |
| Halotestin (Fluoxymesterone) | X | 1 | 4.0 | 1.0 | 1.0 | 20 Jun 2025 |
| IGF-1 LR3 | X | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| LGD-4033 (Ligandrol) | X | 1 | 4.0 | 0.0 | 0.0 | 20 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| NAD+ Injectable | X | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| NandroMix 300 | X | 1 | 4.0 | 0.5 | 0.5 | 8 Jul 2025 |
| P21 | X | 1 | 4.0 | 1.1 | 1.1 | 28 Mar 2025 |
| Propionyl chloride CAS 79-03-8 | X | 1 | 4.0 | 0.6 | 0.6 | 27 Feb 2025 |
| Prostamax | X | 1 | 4.0 | 1.4 | 1.4 | 2 Jul 2025 |
| Romosozumab | X | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X | 1 | 4.0 | 1.8 | 1.8 | 17 Dec 2024 |
| Testosterone Decanoate Raw | X | 1 | 4.0 | 1.6 | 1.6 | 3 Jul 2025 |
| Vilon | X | 1 | 4.0 | 0.2 | 0.2 | 21 May 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Romosozumab | 4.0 | 10mg | 12.3mg | +22.7% | 98.00% | Lab F |
| 24 May 2026 | DHB (1-Test Cyp) | 4.2 | 250mg/ml | 227.3mg/ml | -9.1% | 99.88% | Lab G |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.1 | 10mg | 9.2mg | -8.1% | 97.99% | Lab G |
| 24 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 4.0 | 10g | 9.8g | -2.4% | 98.64% | Lab F |
| 24 May 2026 | Testosterone Decanoate Raw | 4.0 | 10g | 9.0g | -9.9% | 95.28% | Lab C |
| 21 May 2026 | Cabergoline | 4.0 | 50mg | 47.7mg | -4.5% | 98.37% | Lab G |
| 21 May 2026 | IGF-1 LR3 | 4.0 | 5mg | 4.9mg | -2.6% | 99.06% | Lab D |
| 20 May 2026 | P21 | 4.0 | 5mg | 4.8mg | -4.2% | 98.00% | Lab C |
| 19 May 2026 | Halotestin (Fluoxymesterone) | 4.0 | 50mg | 59.6mg | +19.2% | 95.63% | Lab D |
| 29 Jan 2026 | LGD-4033 (Ligandrol) | 4.5 | 20mg | 24.8mg | +23.9% | 96.21% | Lab B |
| 26 Jan 2026 | Andarine S4 | 4.3 | 50mg | 51.8mg | +3.6% | 97.29% | Lab B |
| 9 Jan 2026 | NAD+ Injectable | 5.1 | 250mg/ml | 269.4mg/ml | +7.7% | 98.78% | Lab C |
| 7 Jan 2026 | AICAR Oral | 4.0 | 10mg | 12.3mg | +22.9% | 96.41% | Lab F |
| 6 Jan 2026 | Propionyl chloride CAS 79-03-8 | 4.0 | 100g | 103.2g | +3.2% | 96.47% | Lab A |
| 29 Dec 2025 | BPC157 5mg + TB500 5mg Blend | 4.0 | 50mg | 44.7mg | -10.6% | 95.42% | Lab G |
| 12 Dec 2025 | 5-amino-1MQ | 4.0 | 20mg | 21.7mg | +8.6% | 99.79% | Lab G |
| 23 Nov 2025 | Prostamax | 5.2 | 15mg | 17.8mg | +19.0% | 95.78% | Lab G |
| 17 Nov 2025 | GHRP-6 Acetate | 5.7 | 5mg | 6.2mg | +23.3% | 97.59% | Lab D |
| 14 Nov 2025 | NandroMix 300 | 4.0 | 100mg/ml | 85.0mg/ml | -15.0% | 96.64% | Lab A |
| 17 Oct 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.5 | 15mg | 13.6mg | -9.4% | 98.16% | Lab B |
| 17 Oct 2025 | Vilon | 4.1 | 2mg | 2.2mg | +8.4% | 97.26% | Lab F |
| 9 Oct 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 4.8 | 10mg | 12.0mg | +19.8% | 98.35% | Lab D |